Head-To-Head Contrast: Global Interactive Technologies (NASDAQ:GITS) vs. OptimizeRx (NASDAQ:OPRX)

Global Interactive Technologies (NASDAQ:GITS) and OptimizeRx (NASDAQ:OPRX) are both small-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and valuation.

Institutional & Insider Ownership

0.2% of Global Interactive Technologies shares are owned by institutional investors. Comparatively, 76.5% of OptimizeRx shares are owned by institutional investors. 9.3% of Global Interactive Technologies shares are owned by company insiders. Comparatively, 5.6% of OptimizeRx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Global Interactive Technologies and OptimizeRx”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Global Interactive Technologies	$790,000.00	8.78	-$6.17 million	($0.59)	-3.20
OptimizeRx	$109.43 million	1.23	$5.13 million	$0.26	27.69

OptimizeRx has higher revenue and earnings than Global Interactive Technologies. Global Interactive Technologies is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Global Interactive Technologies has a beta of -0.24, suggesting that its share price is 124% less volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500.

Profitability

This table compares Global Interactive Technologies and OptimizeRx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Global Interactive Technologies	N/A	-104.68%	-93.94%
OptimizeRx	4.69%	10.61%	7.54%

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Global Interactive Technologies and OptimizeRx, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Global Interactive Technologies	1	0	0	0	1.00
OptimizeRx	1	1	6	1	2.78

OptimizeRx has a consensus price target of $17.57, suggesting a potential upside of 144.05%. Given OptimizeRx’s stronger consensus rating and higher possible upside, analysts plainly believe OptimizeRx is more favorable than Global Interactive Technologies.

Summary

OptimizeRx beats Global Interactive Technologies on 13 of the 15 factors compared between the two stocks.

About Global Interactive Technologies

Global Interactive Technologies, Inc. engages in the provision of a global multi-media platform for users to interact with other like-minded users to share appreciation of various types of entertainment and cultures such as K-POP and modern Korean culture. It operates through the FANTOO platform. The company was founded on October 20, 2021 and is headquartered in Seoul, South Korea.

About OptimizeRx

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.